Viet Nam Pharmaceutical - JSC (HSTC:DVN) 5-Year EBITDA Growth Rate: 24.40% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:DVN Viet Nam Pharmaceutical Corp - JSC HSTC:DVN
82 GF Score
Price ₫17,300.00
GF Value ₫21,872.09
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Viet Nam Pharmaceutical - JSC 5-Year EBITDA Growth Rate?

Viet Nam Pharmaceutical - JSC HSTC:DVN -1.73% 82 5-Year EBITDA Growth Rate is 24.40% as of Jun. 2026. GuruFocus rates HSTC:DVN with a GF Score™ of 82/100 and a GF Value™ of ₫21,872.09 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Viet Nam Pharmaceutical - JSC's EBITDA per Share for the six months ended in Jun. 2026 was ₫791.74.

During the past 12 months, Viet Nam Pharmaceutical - JSC's average EBITDA Per Share Growth Rate was 71.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 59.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 24.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Viet Nam Pharmaceutical - JSC was 59.80% per year. The lowest was -13.90% per year. And the median was 18.65% per year.


Viet Nam Pharmaceutical - JSC  (HSTC:DVN) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Viet Nam Pharmaceutical - JSC 5-Year EBITDA Growth Rate Related Terms


HSTC:DVN vs ZTS: 5-Year EBITDA Growth Rate Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Viet Nam Pharmaceutical - JSC's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viet Nam Pharmaceutical - JSC 5-Year EBITDA Growth Rate vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Viet Nam Pharmaceutical - JSC's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Viet Nam Pharmaceutical - JSC's 5-Year EBITDA Growth Rate falls into.


HSTC:DVN
82GF Score
Viet Nam Pharmaceutical Corp - JSC HSTC:DVN
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viet Nam Pharmaceutical - JSC 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 24.40% mean?
Viet Nam Pharmaceutical - JSC (HSTC:DVN) has a 5-Year EBITDA Growth Rate of 24.40% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Viet Nam Pharmaceutical - JSC and its competitors.
Is Viet Nam Pharmaceutical - JSC's 5-Year EBITDA Growth Rate too high?
Viet Nam Pharmaceutical - JSC's current 5-Year EBITDA Growth Rate is 24.40%. Overall, Viet Nam Pharmaceutical - JSC has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Viet Nam Pharmaceutical - JSC's 5-Year EBITDA Growth Rate compare to ZTS?
Viet Nam Pharmaceutical - JSC's 5-Year EBITDA Growth Rate of 24.40% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Drug Manufacturers company?
A good 5-Year EBITDA Growth Rate depends on the Drug Manufacturers industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Viet Nam Pharmaceutical - JSC and its competitors. Viet Nam Pharmaceutical - JSC's current 5-Year EBITDA Growth Rate is 24.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viet Nam Pharmaceutical - JSC stock overvalued right now?
Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC (HSTC:DVN) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫21,872.09, compared to a current price of ₫17,300.00 — trading 20.9% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 24.40%. Viet Nam Pharmaceutical - JSC's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Viet Nam Pharmaceutical - JSC (HSTC:DVN), the current 5-Year EBITDA Growth Rate is 24.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viet Nam Pharmaceutical - JSC (HSTC:DVN) Overvalued in 2026?

Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC stock appears to be undervalued. The current stock price of ₫17,300.00 is trading 20.9% below its estimated GF Value™ of ₫21,872.09. GuruFocus considers Viet Nam Pharmaceutical - JSC to be Modestly Undervalued.

Key valuation signals for HSTC:DVN:

  • 5-Year EBITDA Growth Rate: 24.40%
  • GF Value™: ₫21,872.09 vs. price of ₫17,300.00 (20.9% below fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the HSTC:DVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Viet Nam Pharmaceutical - JSC Business Description

Address 12 Ngo Tat To, Van Mieu Ward, Dong Da District, Hanoi, VNM
Viet Nam Pharmaceutical Corp - JSC is engaged in the manufacturing of drugs. The company provides testing services for drugs and medicinal ingredients.
82GF Score

Get the complete analysis for HSTC:DVN

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫17,300.00
Price
₫21,872.09
GF Value